Cargando…

Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study

BACKGROUND: Although recent guidelines advocate for HbA1c target individualization, a comprehensive criterion for patient categorization remains absent. This study aimed to categorize HbA1c variability levels and explore the relationship between glycemic control, cardiovascular outcomes, and mortali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pei, Junyu, Wang, Xiaopu, Pei, Zeyu, Hu, Xinqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612188/ https://www.ncbi.nlm.nih.gov/pubmed/37891565 http://dx.doi.org/10.1186/s12933-023-02026-9

Ejemplares similares

High‐density lipoprotein cholesterol levels are associated with major adverse cardiovascular events in male but not female patients with hypertension
por: Wang, Xiaopu, et al.
Publicado: (2021)

Association between admission systolic blood pressure and major adverse cardiovascular events in patients with acute myocardial infarction
por: Pei, Junyu, et al.
Publicado: (2020)

Waist circumference is associated with major adverse cardiovascular events in male but not female patients with type-2 diabetes mellitus
por: Xing, Zhenhua, et al.
Publicado: (2020)

Hb Levels and Sex Differences in Relation to Short-Term Outcomes in Patients With Acute Myocardial Infarction
por: Pei, Junyu, et al.
Publicado: (2021)

HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target
por: Ceriello, Antonio, et al.
Publicado: (2022)

HbA1c trajectory and cardiovascular outcomes: an analysis of data from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study
por: Wang, Jun-Sing, et al.
Publicado: (2021)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

The Brain-Heart Connection in Takotsubo Syndrome: The Central Nervous System, Sympathetic Nervous System, and Catecholamine Overload
por: Wang, Xiaopu, et al.
Publicado: (2020)

HbA1c, Coronary atheroma progression and cardiovascular outcomes
por: Dykun, Iryna, et al.
Publicado: (2022)

Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial
por: Ceriello, Antonio, et al.
Publicado: (2020)

Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
por: Feng, Xiaojing, et al.
Publicado: (2021)

HbA1c Variability and Cardiovascular Events in Patients with Prostate Cancer Receiving Androgen Deprivation Therapy
por: Chan, Jeffrey Shi Kai, et al.
Publicado: (2022)

Traditional Cardiovascular Risk Factors and Coronary Collateral Circulation: A Meta-Analysis
por: Pei, Junyu, et al.
Publicado: (2021)

Cardiovascular Autonomic Neuropathy Predicts Higher HbA1c Variability in Subjects with Type 2 Diabetes Mellitus
por: Yang, Yeoree, et al.
Publicado: (2018)

Relative contributions of preprandial and postprandial glucose exposures, glycemic variability, and non-glycemic factors to HbA(1c) in individuals with and without diabetes
por: Færch, Kristine, et al.
Publicado: (2018)

Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population
por: Hernandez, Domingo, et al.
Publicado: (2013)

Plasma metabolites mediate the effect of HbA1c on incident cardiovascular disease
por: Dong, Xuesi, et al.
Publicado: (2019)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Relative contributions of fasting and postprandial glucose increments, glycemic variability, and non‐glycemic factors to HbA1c in individuals with type 1 diabetes
por: Zhou, Yongwen, et al.
Publicado: (2023)

HbA1C Variability Is Strongly Associated With the Severity of Cardiovascular Autonomic Neuropathy in Patients With Type 2 Diabetes After Longer Diabetes Duration
por: Lai, Yun-Ru, et al.
Publicado: (2019)

An Evaluation of Point-of-Care HbA1c, HbA1c Home Kits, and Glucose Management Indicator: Potential Solutions for Telehealth Glycemic Assessments
por: Zaharieva, Dessi P., et al.
Publicado: (2022)

The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c
por: Xu, Feng, et al.
Publicado: (2014)

HbA1c variability and long-term glycemic control are linked to peripheral neuropathy in patients with type 1 diabetes
por: Pinto, M. V., et al.
Publicado: (2020)

Association of HbA1c With All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes
por: Lu, Jingyi, et al.
Publicado: (2021)

Relationship of Obesity to Adverse Events Among Patients With Mean 10‐Year History of Type 2 Diabetes Mellitus: Results of the ACCORD Study
por: Xing, Zhenhua, et al.
Publicado: (2018)

HbA1c is a predictive factor of severe coronary stenosis and major adverse cardiovascular events in patients with both type 2 diabetes and coronary heart disease
por: Jiao, Xiaojuan, et al.
Publicado: (2023)

HbA1c at term delivery and adverse pregnancy outcome
por: Hong, Jesrine Gek Shan, et al.
Publicado: (2022)

Short‐term and long‐term outcomes of revascularization interventions for patients with severely reduced left ventricular ejection fraction: a meta‐analysis
por: Pei, Junyu, et al.
Publicado: (2020)

Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA(1c) values
por: Li, Feng-fei, et al.
Publicado: (2017)

Long‐Term Visit‐to‐Visit Glycemic Variability as a Predictor of Major Adverse Limb and Cardiovascular Events in Patients With Diabetes
por: Hsu, Jung‐Chi, et al.
Publicado: (2023)

Traditional cardiovascular risk factors and coronary collateral circulation: Protocol for a systematic review and meta-analysis of case-control studies
por: Xing, Zhenhua, et al.
Publicado: (2018)

Heterogeneous treatment effects of intensive glycemic control on major adverse cardiovascular events in the ACCORD and VADT trials: a machine-learning analysis
por: Edward, Justin A., et al.
Publicado: (2022)

Glycemic Profiles of Healthy Individuals with Low Fasting Plasma Glucose and HbA1c
por: Nomura, Kyoko, et al.
Publicado: (2011)

Relationship between HbA1c, fructosamine and clinical assessment of glycemic control in dogs
por: Norris, Olga, et al.
Publicado: (2022)

On the Association between Implant-Supported Prosthesis and Glycemic Control (HbA1c Values)
por: Masri, Daya, et al.
Publicado: (2022)

The Role of Glycemic Variability in Cardiovascular Disorders
por: Alfieri, Valentina, et al.
Publicado: (2021)

ODP237 Relation Between Long Term Glycemic Variability (LTGV) and HbA1c Time-In-Range in Diabetic Patients.
por: Delgado-Vazquez, Angel Jesus, et al.
Publicado: (2022)

Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c
por: Jeon, Ja Young, et al.
Publicado: (2013)

Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors
por: Kurukulasuriya, L Romayne, et al.
Publicado: (2010)

Association of Low Fasting Glucose and HbA1c With Cardiovascular Disease and Mortality: The MESA Study
por: Mongraw-Chaffin, Morgana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1r7qo88sfi17hpe9d1l073m63o